Brioli, A; Zannetti, Ba; Zamagni, E; Tacchetti, P; Pantani, L; Mancuso, K; Pezzi, A; Rocchi, Serena; Cavo, M, Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma., «HAEMATOLOGICA», 2014, 99, pp. 242 - 243 [articolo]Open Access
Cristina Papayannidis, Mariachiara Abbenante, Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, Emanuela Ottaviani, Anna Ferrari, Viviana Guadagnuolo, Chiara Sartor, Simona Soverini, Caterina De Benedittis, Carmen Baldazzi, Michele Baccarani, Michele Cavo, Giovanni Martinelli, PKC412 (Midostaurin) is safe and highly effective in Systemic Mastocytosis patients: the Bologna experience, «CANCER RESEARCH», 2014, 73, pp. 2082 - 2082 [abstract]
Zamagni, Elena; Nanni, Cristina; Tacchetti, Paola; Pantani, Lucia; Marzocchi, Giulia; Zannetti, BEATRICE ANNA; Terragna, Carolina; Mancuso, Katia; Rocchi, S; Pezzi, Annalisa; Testoni, Nicoletta; Fanti, Stefano; Cavo, Michele, Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2014, 14, pp. 101 - 104 [articolo]
Palumbo A.; Bringhen S.; Kumar S.K.; Lupparelli G.; Usmani S.; Waage A.; Larocca A.; Van Der Holt B.; Musto P.; Offidani M.; Petrucci M.T.; Evangelista A.; Zweegman S.; Nooka A.K.; Spencer A.; Dimopoulos M.A.; Hajek R.; Cavo M.; Richardson P.; Lonial S.; Ciccone G.; Boccadoro M.; Anderson K.; Barlogie B.; Sonneveld P.; McCarthy P.L., Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: A meta-analysis of individual patient data, «THE LANCET ONCOLOGY», 2014, 15, pp. 333 - 342 [articolo]
Brioli A;Giles H;Pawlyn C;Campbell JP;Kaiser MF;Melchor L;Jackson GH;Gregory WM;Owen RG;Child JA;Davies FE;Cavo M;Drayson MT;Morgan GJ, Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome., «BLOOD», 2014, 123, pp. 3414 - 3419 [articolo]
Melchor L;Brioli A;Wardell CP;Murison A;Potter NE;Kaiser MF;Fryer RA;Johnson DC;Begum DB;Hulkki Wilson S;Vijayaraghavan G;Titley I;Cavo M;Davies FE;Walker BA;Morgan GJ, Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma., «LEUKEMIA», 2014, 28, pp. 1705 - 1715 [articolo]
Brioli A;Melchor L;Cavo M;Morgan GJ, The impact of intra-clonal heterogeneity on the treatment of multiple myeloma., «BRITISH JOURNAL OF HAEMATOLOGY», 2014, 165, pp. 441 - 454 [articolo]
Brioli A;Melchor L;Titley I;Vijayaraghavan G;Stephens C;Zeisig A;Pawlyn C;Cavo M;Morilla R;Davies FE;Morgan GJ, The impact of long-term lenalidomide exposure on the cellular composition of bone marrow., «LEUKEMIA & LYMPHOMA», 2014, 55, pp. 2665 - 2668 [articolo]
Caterina De Benedittis, Simona Soverini, Cristina Papayannidis, Michela Rondoni, Sabrina Colarossi, Francesca Dal Pero, Luca Zazzeroni, Roberta Zanotti, Giovanna De Matteis, Serena Merante, Chiara Elena, Federica Irene Grifoni, Massimiliano Bonifacio, Omar Perbellini, Giorgina Specchia, Livio Pagano, Domenica Gangemi, Patrizia Bonadonna, Lisa Pieri, Michele Cavo, Giovanni Martinelli, Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis, «BLOOD», 2014, 124, pp. 1856 - 1856 [abstract]
De Benedittis C, Soverini S, Papayannidis C, Rondoni M, Colarossi S, Dal Pero F, Zazzeroni L, Zanotti R, De Matteis G, Merante S, Elena C, Grifoni FI, Bonifacio M, Perbellini O, Specchia G, Pagano L, Gangemi D, Bonadonna P, Pieri L, Cavo M, Martinelli G, Ultra-Deep Sequencing (UDS) allows more sensitive detection of the D816V and other kit gene mutations in systemic mastocytosis, in: ABSTRACTS, 2014, pp. 29 - 30 (atti di: ELN Frontiers Meeting 2014 – where science meets clinical practice, Berlin, Germany, 16-19 October 2014) [atti di convegno-abstract]
Papayannidis, Cristina; Ferrari, Anna; Paolini, Stefania; Baldazzi, Carmen; Sartor, Chiara; Abbenante, Mariachiara; Marconi, Giovanni; Parisi, Sarah; Volpato, Francesca; Iacobucci, Ilaria; Padella, Antonella; Guadagnuolo, Viviana; Perricone, Margherita; Robustelli, Valentina; Venturi, Claudia; Simonetti, Giorgia; Conficoni, Alberto; Mancuso, Katia; Zannetti, BEATRICE ANNA; Ottaviani, Emanuela; Zuffa, Elisa; Franchini, Eugenia; Testoni, Nicoletta; Cavo, Michele; Martinelli, Giovanni, Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome, «BLOOD», 2014, 124, pp. 484 - 484 [abstract]
Stanzani M;Lewis RE;Fiacchini M;Ricci P;Tumietto F;Viale P;Ambretti S;Baccarani M;Cavo M;Vianelli N, A risk prediction score for invasive mold disease in patients with hematological malignancies, «PLOS ONE», 2013, 8, Article number: e75531, pp. 1 - 9 [articolo]Open Access
Terragna, Carolina; Remondini, Daniel; Martello, Marina; Pezzi, Annalisa; Patriarca, Francesca; Levi, Anna; Pantani, Lucia; Donnarumma, Daniela; Montanaro, Lorenzo; Crippa, Claudia; Bringhen, Sarah; Rambaldi, Alessandro; Offidani, Massimo; Corradini, Paolo; Narni, Franco; Fioritoni, Giuseppe; Zaccaria, Alfonso; Baldini, Luca; Caravita, Tommaso; La Nasa, Giorgio; Cortellazzo, Sergio; Martinelli, Giovanni; Cavo, Michele, A 41-gene signature predicts complete response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) as induction therapy prior to autologous stem-cell transplantation (ASCT) in multiple myeloma (MM)., in: Cancer Research, 2013, pp. 2207 - 2207 (atti di: 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, USA, April 06 -10, 2013) [atti di convegno-abstract]
Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S;
Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C;
Manzoli L; Martinelli G; Cocco L; Cavo M, AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE
EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS, in: HAEMATOLOGICA, 2013, 98, pp. 200 - 200 (atti di: 44° Congress of the Italian Society of Hematology, VERONA, 20-23 OTTOBRE 2013) [Contributo in Atti di convegno]
Brioli A;Kaiser MF;Pawlyn C;Wu P;Gregory WM;Owen R;Ross FM;Jackson GH;Cavo M;Davies FE;Morgan GJ, Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma., «LEUKEMIA & LYMPHOMA», 2013, 54, pp. 1975 - 1981 [articolo]
